Table 2.
Study | Sample Size | Treatment Design | Age | Sex | Type of Treatment | Criteria of Study |
---|---|---|---|---|---|---|
Yagci et al. [12] |
38 | 23 patients (test) 15 patients (control) |
10.1 ±1.1 9.7±1.4 |
20 F 18 M |
RME | Transversal roll Sagittal pitch |
Tecco et al. [13] |
45 | 23 patients (test) 22 patients (control) |
8-15 years 8.1±2.0 |
45 F | RPE | CVT/EVT OPT/Ver CVT/Ver EVT/Ver SN/OPT SN/CVT PP/OPT PP/CVT MP/OPT MP/CVT |
Mc Guinness et al. [14] | 79 | 43 patients (test) 36 patients (control) |
10-16 years | 49F 30M |
RME | OPT/NSL CVT/NSL OPT/CVT NSL/VER OPT/HOR CVT/HOR |
Tecco et al. [15] |
45 | 23 patients (test) 22 patients (control) |
8-15 years 8.1±2.0 |
45 F | RPE | CVT/EVT OPT/Ver CVT/Ver EVT/Ver SN/OPT SN/CVT PP/OPT PP/CVT MP/OPT MP/CVT |
Yagci et al. [16] |
45 | 15 patients (test 1) 15 patients (test 2) 15 patients (control) |
9.6±1.3 9.5±1.5 9.8±1.6 |
22F 23M |
RPE; Conventional facemask therapy; Modified facemask therapy |
Transversal roll Sagittal pitch |
Kilinc et al. [17] |
35 | 18 patients (test) 17 patients (control) |
10.9 10.9 |
20 F 15M |
RPE | NSL/ML NSL/CVT |